Medical device company Vivos Therapeutics has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its device that treats moderate to severe obstructive sleep apnea (OSA) and snoring in children.
This device, part of Vivos' CARE line, is designed for children ages 6 to 17 who experience snoring or OSA and need orthodontic treatment.
.I3dcZKubTl.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.I3dcZKubTl.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
